Skip to main content
. 2022 Jan 10;116:210–215. doi: 10.1016/j.ijid.2022.01.015

Table 1.

Study design based on ClinicalTrials.gov database compared with COVID-19 and others

Study type COVID-19 (n=6408) Others (n=48926) ALL (n=55334) P value
Interventional Studies 3622(56.52%) 37539(76.73%) 41161(74.39%) <0.001
Observational Studies 2786(43.48%) 11387(23.27%) 14173(25.61%)
-Patient Registry Studies 369(5.76%) 1491(3.05%) 1860(3.36%) <0.001